Broker notice of proposed ANIP share resale (4,000; 3,312)

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice proposing resale of common stock.

Accepted by SEC EDGAR 03/05/2026 - 05:22 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice proposing resale of common stock. The filing lists 4,000 restricted shares dated 04/10/2024 and 3,312 shares tied to a stock option exercise dated 03/05/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ANIP's Form 144 filed by Morgan Stanley indicate?

It indicates a proposed resale of common stock by a broker-affiliated filer. The notice lists 4,000 restricted shares (dated 04/10/2024) and 3,312 shares from a stock option exercise (dated 03/05/2026), per the excerpt.

Does the Form 144 show completed sales for ANIP?

No; the filing lists proposed securities to be sold. It shows restricted stock dated 04/10/2024 (4,000) and a stock option exercise dated 03/05/2026 (3,312), without documenting completed trades.

Who is the filer on the ANIP Form 144 notice?

The filer is listed as Morgan Stanley Smith Barney LLC Executive Financial Services with an address at 1 New York Plaza, 8th Floor, New York, NY 10004, according to the provided excerpt.

What types of securities are included in the ANIP notice?

The excerpt lists common stock in two categories: restricted stock (4,000 shares dated 04/10/2024) and shares issued via a stock option exercise (3,312 shares dated 03/05/2026).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001674236
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI Pharmaceuticals, Inc.
SEC File Number	001-31812
Address of Issuer	210 Main Street West Baudette MINNESOTA 56623
Phone	(218) 634-3500
Name of Person for Whose Account the Securities are To Be Sold	STEPHEN P CAREY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7312	552017.46	22414104	03/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/10/2024	Restricted Stock	Issuer			4000	04/10/2024	Not Applicable
Common	03/05/2026	Stock Option Exercise	Issuer			3312	03/05/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Stephen Philip Carey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)